Macrophages acquire fibroblast characteristics in a rat model of proliferative vitreoretinopathy

Ophthalmic Research

Volumn 45, Issue 4, 2011, Pages 180-190

  Lin, Miao Li ^a   Li, Yong Ping ^a   Li, Zhan Rong ^a   Lin, Jian Xian ^a   Zhou, Xiao Lai ^a   Liang, Dan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Fibroblast; Macrophages; Proliferative vitreoretinopathy

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD68 ANTIGEN; CYTOKERATIN; GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMICROSCOPY; CELL TYPE; CELL VIABILITY; CLINICAL EXAMINATION; DISEASE COURSE; EXTRACELLULAR MATRIX; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA BLOOD VESSEL; VITREORETINOPATHY;

ACTINS; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL TRANSDIFFERENTIATION; DISEASE MODELS, ANIMAL; FIBROBLASTS; GLIAL FIBRILLARY ACIDIC PROTEIN; INTRAVITREAL INJECTIONS; KERATINS; MACROPHAGES, PERITONEAL; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; VIMENTIN; VITREORETINOPATHY, PROLIFERATIVE;

EID: 78049390749     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320496     Document Type: Article

References (31)

1. Pastor JC, de la Rua ER, Martin F: Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res 2002; 21: 127-144. (Pubitemid 34242710)
2. Pastor JC: Proliferative vitreoretinopathy: an overview. Surv Ophthalmol 1998; 43: 3-18. (Pubitemid 28364465)
3. Lewis H, Aaberg TM, Abrams GW: Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy. Am J Ophthalmol 1991; 111: 8-14.
4. Lewis H, Aaberg TM: Causes of failure after repeat vitreoretinal surgery for recurrent proliferative vitreoretinopathy. Am J Ophthalmol 1991; 111: 15-19.
5. Cordeiro MF, Schultz GS, Ali RR, Bhattacharya SS, Khaw PT: Molecular therapy in ocular wound healing. Br J Ophthalmol 1999; 83: 1219-1224. (Pubitemid 29511800)
6. Nagasaki H, Shinagawa K, Mochizuki M: Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res 1998; 17: 77-98. (Pubitemid 28040754)
7. Esser P, Heimann K, Wiedemann P: Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations. Br J Ophthalmol 1993; 77: 731-733. (Pubitemid 23326062)
8. Martin F, Pastor JC, De La Rua ER, Mayo- Iscar A, Garcia-Arumi J, Martinez V, Fernandez N, Saornil MA: Proliferative vitreoretinopathy: cytologic findings in vitreous samples. Ophthalmic Res 2003; 35: 232-238. (Pubitemid 36736952)
9. Gordon S: The macrophage: past, present and future. Eur J Immunol 2007; 37(suppl 1):S9-S17.
10. Naito M: Macrophage differentiation and function in health and disease. Pathol Int 2008; 58: 143-155. (Pubitemid 351190168)
11. Wiedemann P: Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferativediabetic retinopathy, and retinal degeneration. Surv Ophthalmol 1992; 36: 373-384.
12. Yang P, de Vos AF, Kijlstra A: Macrophages in the retina of normal Lewis rats and their dynamics after injection of lipopolysaccharide. Invest Ophthalmol Vis Sci 1996; 37: 77-85. (Pubitemid 26036519)
13. Charteris DG: Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol 1995; 79: 953-960.
14. Bochaton-Piallat ML, Kapetanios AD, Donati G, Redard M, Gabbiani G, Pournaras CJ: TGF-β 1, TGF-β receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Invest Ophthalmol Vis Sci 2000; 41: 2336-2342. (Pubitemid 30451011)
15. Forrester JV, Docherty R, Kerr C, Lackie JM: Cellular proliferation in the vitreous: the use of vitreous explants as a model system. Invest Ophthalmol Vis Sci 1986; 27: 1085-1094. (Pubitemid 16062045)
16. Ross R, Everett NB, Tyler R: Wound healing and collagen formation. VI. The origin of the wound fibroblast studied in parabiosis. J Cell Biol 1970; 44: 645-654.
17. Reuter U, Champion C, Kain HL: Transdifferentiation of human monocytes into fibroblast- like cells in vitro. Ger J Ophthalmol 1995; 4: 182-187.
18. Ninomiya K, Takahashi A, Fujioka Y, Ishikawa Y, Yokoyama M: Transforming growth factor-β signaling enhances transdifferentiation of macrophages into smooth musclelike cells. Hypertens Res 2006; 29: 269-276. (Pubitemid 43853273)
19. Abu EA, Struyf S, Van Damme J, Geboes K: Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes. Br J Ophthalmol 2008; 92: 699-704. (Pubitemid 351684185)
20. Weller M, Heimann K, Wiedemann P: Immunochemical studies of epiretinal membranes using APAAP complexes: evidence for macrophage involvement in traumatic proliferative vitreoretinopathy. Int Ophthalmol 1988; 11: 181-186. (Pubitemid 19005038)
21. Hui YN, Goodnight R, Sorgente N, Ryan SJ: Fibrovascular proliferation and retinal detachment after intravitreal injection of activated macrophages in the rabbit eye. Am J Ophthalmol 1989; 108: 176-184. (Pubitemid 19197952)
22. Burke JM, Twining SS: Vitreous macrophage elicitation: generation of stimulants for pigment epithelium in vitro. Invest Ophthalmol Vis Sci 1987; 28: 1100-1107. (Pubitemid 17089948)
23. Weller M, Heimann K, Wiedemann P: Demonstration of mononuclear phagocytes in a human epiretinal membrane using a monoclonal anti-human macrophage antibody. Graefes Arch Clin Exp Ophthalmol 1988; 226: 252-254.
24. Hui YN, Sorgente N, Ryan SJ: Posterior vitreous separation and retinal detachment induced by macrophages. Graefes Arch Clin Exp Ophthalmol 1987; 225: 279-284. (Pubitemid 17092222)
25. Behar-Cohen FF, Thillaye-Goldenberg B, de Bizemont T, Savoldelli M, Chauvaud D, de Kozak Y: EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR. Invest Ophthalmol Vis Sci 2000; 41: 3915-3924.
26. Agrawal RN, He S, Spee C, Cui JZ, Ryan SJ, Hinton DR: In vivo models of proliferative vitreoretinopathy. Nat Protoc 2007; 2: 67-77. (Pubitemid 47040070)
27. Miller W, Makova KD, Nekrutenko A, Hardison RC: Comparative genomics. Annu Rev Genomics Hum Genet 2004; 5: 15-56. (Pubitemid 39362740)
28. Canto SM, Gallo JE, Dodds RA, Suburo AM: A mouse model of proliferative vitreoretinopathy induced by dispase. Exp Eye Res 2002; 75: 491-504. (Pubitemid 35435605)
29. Casaroli MR, Vilaro S: The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1994; 35: 2791-2803. (Pubitemid 24149792)
30. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, Brown PO: Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 2002; 99: 12877-12882.
31. Liu T, Warburton RR, Guevara OE, Hill NS, Fanburg BL, Gaestel M, Kayyali US: Lack of MK2 inhibits myofibroblast formation and exacerbates pulmonary fibrosis. Am J Respir Cell Mol Biol 2007; 37: 507-517.(Pubitemid 350058181)